Status:
COMPLETED
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Young Adults
Lead Sponsor:
Auburn University
Collaborating Sponsors:
Edward Via College of Osteopathic Medicine-Auburn
The Peanut Institute
Conditions:
Sarcopenia
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
This study will evaluate the adaptations in skeletal muscle that occur in response to 10 weeks of weight training with or without peanut protein supplementation in untrained men and women ages 18-30
Detailed Description
This is a two-phase study using both novel and conventional methods to assess how PP supplementation affects muscle tissue in young adults who engage in resistance training. These two phases will be c...
Eligibility Criteria
Inclusion
- body mass index (body mass/height squared) less than 35 kg/m2
- resting blood pressure averaging less than 140/90 mmHg (with or without medication)
Exclusion
- known peanut allergy
- actively participating in resistance training for more than 2 days/week
- any known overt cardiovascular or metabolic disease
- metal implants that will interfere with x-ray procedures
- medically necessary radiation exposure in the last six months (except dental x-ray)
- any medical condition that would contradict participating in an exercise program, giving blood or donating a skeletal muscle biopsy (i.e. blood clotting disorder or taking blood thinners)
- pregnant or trying to become pregnant
Key Trial Info
Start Date :
February 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04707963
Start Date
February 6 2021
End Date
May 31 2021
Last Update
June 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Auburn University
Auburn, Alabama, United States, 36849